Timing of Co-occurring Chronic Conditions in Children With Neurologic Impairment

Joanna Thomson1, Matt Hall2, Katherine Nelson3

  • 1Division of Hospital Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and College of Medicine, University of Cincinnati, Cincinnati, Ohio; joanna.thomson@cchmc.org.

Pediatrics
|January 8, 2021
PubMed

Insights

Children with neurologic impairment (NI) develop multiple chronic conditions early in life. This highlights the need for early intervention and tailored care for these complex pediatric cases.

Area of Science:

  • Pediatric Health
  • Neurology
  • Public Health

Background:

  • Children with neurologic impairment (NI) face a high risk of developing co-occurring chronic conditions.
  • These conditions increase medical complexity and morbidity in affected children.
  • Understanding the prevalence and onset of these conditions is crucial for effective management.

Purpose of the Study:

  • To assess the prevalence of co-occurring chronic conditions in children with neurologic impairment (NI).
  • To determine the timing of onset for these conditions in pediatric populations with NI.
  • To analyze age-related trends in multimorbidity among children with NI.

Main Methods:

  • Longitudinal analysis of 6229 children diagnosed with NI by age 3, continuously enrolled in Medicaid from 2009-2015.
  • NI defined using diagnostic codes for neurologic, genetic, and metabolic conditions causing functional impairments.
  • Co-occurring conditions assessed using the Agency for Healthcare Research and Quality Chronic Condition Indicator system.

Main Results:

  • Static NI was most common (56.3%), with cerebral palsy (10.0%) as the leading diagnosis.
  • Respiratory (86.5%) and digestive (49.4%) systems were most frequently affected by co-occurring conditions.
  • Mean number of conditions increased with age: 3.7 at 2 years, 4.6 at 4 years, and 5.1 at 6 years. By age 6, 12.8% had ≥9 conditions.

Conclusions:

  • Children with NI in Medicaid experience significant multimorbidity early in life.
  • Early identification of the timing and types of multimorbidity is essential.
  • Optimizing preventive care and case management health services for these children is critical.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
557
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
603
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.2K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
107
Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
416